Sutureless Perceval Aortic Valve Replacement: Results of Two European Centers

Folliguet, Thierry; Laborde, F; Zannis, Konstantinos; Ghorayeb, G; Haverich, Axel; Shrestha, Malakh

doi:10.1016/j.athoracsur.2012.01.071

Cited by 207 publications

(208 citation statements)

References 21 publications

Supporting

Mentioning

189

Contrasting

Unclassified

Order By: Relevance

“…All 14 studies were observational, which included 7 prospective (11,14,16,(19)(20)(21)(22) and 7 retrospective studies (10,12,13,15,17,18,23). There were no randomized controlled trials.…”

Section: Quality Of Evidencementioning

confidence: 99%

Early results of the Sorin® Perceval S sutureless valve: systematic review and meta-analysis

Sian

Selvakumar

et al. 2017

J. Thorac. Dis.

View full text Add to dashboard Cite

Background: Minimally invasive aortic valve replacement (MAVR) has demonstrated a benefit with respect to increased patient satisfaction due to minimised pain and earlier recovery. Sutureless valves may benefit MAVR and conventional aortic valve replacement (AVR) by reducing operative times and blood transfusion requirements. The Perceval valve (Sorin, Salluggia, Italy) is a self-expanding prosthesis made from bovine pericardium mounted in a nitinol stent, designed to simplify the implantation of an aortic valve. This metaanalysis evaluates the clinical, haemodynamic, and survival outcomes of the Perceval sutureless valve.Methods: An electronic search of 4 databases was performed from January 2000 to December 2016.Primary outcomes included mortality and stroke. Secondary outcomes included minimally invasive access, paravalvular leak, overall long-term survival, postoperative echocardiographic findings, and functional class improvement.Results: After the application of inclusion and exclusion criteria, 14 of 66 relevant articles were selected for assessment. Of these 14 studies, a total number of 2,505 patients were included. The current evidence on the Perceval valve for aortic valve disease is limited to observational studies only. Minimally invasive surgery was performed in 976 patients, of which 336 were via the right anterior thoracotomy approach. The Perceval M and L sutureless valves were the most frequently used, 782 and 770 respectively. The incidence of major adverse events included 30-day mortality (0 to 4.9%), cerebrovascular accident (0 to 3%), permanent pacemaker insertion (0 to 17%), moderate to severe paravalvular leak (0 to 8.6%), and re-operation (0 to 4.8%). Post-operative mean aortic valve gradient ranged from 9 to 15.9 mmHg and post-operative New York Heart Association (NYHA) Class I or II ranged from 82% to 96%. The 1-year survival ranged from 86% to 100%; and 5-year survival was 71.3% to 85.5% in two studies. Conclusions:The Perceval valve is associated with excellent post-operative results in MAVR and in conventional AVR. Larger randomised controlled studies are required to evaluate the long-term efficacy of the prosthesis.

show abstract

“…All 14 studies were observational, which included 7 prospective (11,14,16,(19)(20)(21)(22) and 7 retrospective studies (10,12,13,15,17,18,23). There were no randomized controlled trials.…”

Section: Quality Of Evidencementioning

confidence: 99%

Early results of the Sorin® Perceval S sutureless valve: systematic review and meta-analysis

Sian

Selvakumar

et al. 2017

J. Thorac. Dis.

View full text Add to dashboard Cite

show abstract

“…Folliguet reported recently the results of a series of 208 high-risk patients operated in 2 European Centers [51]. Median follow up was 10 ± 20 months and the total accumulated followup was 156 patient-years.…”

Section: The Perceval S Sutureless Valvementioning

confidence: 99%

“…The preliminary results of the trial confirmed the safety and efficacy of the Perceval S sutureless aortic valve. In this highrisk subset of patients, shortening the aortic cross-clamp and ECC times may help to reduce mortality and morbidity [51,52,53].…”

Section: The Perceval S Sutureless Valvementioning

confidence: 99%

Recent developments for surgical aortic valve replacement: The concept of sutureless valve technology

Carrel¹,

Englberger²,

Stalder³

2013

Open J Cardiol

View full text Add to dashboard Cite

show abstract

“…The design of these prostheses intends to be an alternative to the traditional prostheses (stented or stentless) used in conventional open-heart surgery (Folliguet et al, 2012). For implantation of these valves, only 1 to 3 sutures are needed, compared to the 12-15 sutures needed for conventional valves.…”

Section: Sutureless Bioprosthesesmentioning

confidence: 99%

“…Due to the relative ease of implantation, it has also been advocated, that these valves could favor the expansion of minimally invasive approaches (Shrestha et al, 2009). (B) The Perceval S sutureless biological valve (Sorin Group, Saluggia, Italy) (Folliguet et al, 2012).…”

Section: Sutureless Bioprosthesesmentioning

confidence: 99%

015 * Propensity Score Analysis of Outcomes Following Minimally Invasive Versus Conventional Aortic Valve Replacement

Shehada

Voß

Elhmidi

et al. 2014

Interactive CardioVascular and Thoracic Surgery

View full text Add to dashboard Cite

show abstract

Sutureless Perceval Aortic Valve Replacement: Results of Two European Centers

Cited by 207 publications

References 21 publications

Early results of the Sorin® Perceval S sutureless valve: systematic review and meta-analysis

Early results of the Sorin® Perceval S sutureless valve: systematic review and meta-analysis

Recent developments for surgical aortic valve replacement: The concept of sutureless valve technology

015 * Propensity Score Analysis of Outcomes Following Minimally Invasive Versus Conventional Aortic Valve Replacement

Contact Info

Product

Resources

About